Plus   Neg

Quidel Corp. (QDEL) Is Climbing After FDA Clearance

Quidel Corp. (QDEL) announced after the bell Monday that it has received 510(k) clearance from the FDA for its Sofia Lyme FIA. The stock is now up 2.17 on 7K shares.

Quidel dipped in early trade Monday, but settled into a range for the bulk of the session. The stock finished with a loss of 0.55 at $43.07.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT